Weihong Jin

Statistics

Publications

Citations

833

H-Index

Active since

2004

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Weihong Jin is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in signal transduction, erk signaling, and protein kinase cascades.

Publications per year

2004–2018

Publications

Discovery of a Novel ERK Inhibitor with Activity in Models of Acquired Resistance to BRAF and MEK Inhibitors

Erick J. Morris, Sharda Jha, Clifford R. Restaino et al. · Cancer Discovery · 2013 · 685 citations · Full text

Medicine, Oncology, Pharmacology +17

Discovery of Novel, Dual Mechanism ERK Inhibitors by Affinity Selection Screening of an Inactive Kinase

Yongqi Deng, Gerald W. Shipps, Alan Cooper et al. · Journal of Medicinal Chemistry · 2014 · 51 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

MK-8353: Discovery of an Orally Bioavailable Dual Mechanism ERK Inhibitor for Oncology

Sobhana Babu Boga, Yongqi Deng, Liang Zhu et al. · ACS Medicinal Chemistry Letters · 2018 · 51 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Analysis of the ERK1,2 transcriptome in mammary epithelial cells

Constance J. Grill, Ferdous Gheyas, Priya Dayananth et al. · Biochemical Journal · 2004 · 31 citations · Full text

Life Sciences, Molecular Biology, Gene Expression +16

Expression and purification of phosphorylated and non-phosphorylated human MEK1

Catherine K. Smith, Donna Carr, Todd Mayhood et al. · Protein Expression and Purification · 2006 · 15 citations

Life Sciences, Biochemistry, Molecular Biology +9

1–5 of 5